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Abstract The mechanism of a lower incidence of dermato-
logical manifestations in patients treated with enalapril com-
pared to patients treated with other ACE-inhibitors, e.g., cap-
topril, is not known. The finding that prolidase plays an im-
portant role in collagen biosynthesis and that some
angiotensin-converting enzyme inhibitors affect prolidase ac-
tivity led us to evaluate its effect on collagen biosynthesis in
cultured human skin fibroblasts. Since insulin-like growth
factor (IGF-I) and transforming growth factor beta 1
(TGF-β1) are the most potent stimulators of both collagen
biosynthesis and prolidase activity, and prolidase is regulated
by β1 integrin signaling, the effect of enalapril and enalaprilat
on IGF-IR, TGF-β1, and β1 integrin receptor expressions was
evaluated. Cells were treated with milimolar concentrations
(0.3 and 0.5 mM) of enalapril and enalaprilat for 24 h. The
activity of prolidase was determined by colorimetic assay.
Collagen biosynthesis was evaluated by radiometric assay.
Expression of signaling proteins was evaluated using
Western blot. It was found that enalapril- and enalaprilat-
dependent increase in prolidase activity and expression was
accompanied by parallel increase in collagen biosynthesis.
The exposure of the cells to 0.5 mM enalapril and enalaprilat
contributed to increase in IGF-IR and α2β1 integrin receptor
as well as TGF-β1 and NF-κB p65 expressions. Enalapril-
and enalaprilat-dependent increase of collagen biosynthesis
in fibroblasts results from increase of prolidase activity and
expression, which may undergo through activation of α2β1
integrin and IGF-IR signaling as well as upregulation of
TGF-β1 and NF-κB p65, the inhibitor of collagen gene
expression.




proline, a prodrug, is converted by deesterification to
angiotensin-converting enzyme inhibitor (ACE-I), enalaprilat,
(S)-1-[N-(1-carboxy-3-phenylpropyl)-L-alanyl]-L-proline
dihydrate, commonly used to control hypertension
(Ovchinnikov et al. 2009). It was the first dicarboxylate-
containing ACE inhibitor, which was developed to overcome
the limitations of captopril. The sulfhydryl moiety was re-
placed by a carboxylate moiety, but additional modifications
were required in its structure to achieve a similar potency to
captopril.
It was documented that treatment of hypertensive patients
with enalaprilat gives a lower incidence of dermatological
manifestations than results from other ACE-I treatment—cap-
topril (Davies et al. 1984). Structurally, enalaprilat is a dipep-
tide having L-proline as the C-terminal residue. Dipeptides of
the x-pro type are substrates exclusively for prolidase. In con-
trast to captopril, enalaprilat had no inhibitory effect on por-
cine kidney prolidase (PKP) (King et al. 1989). This dipepti-
dase is present in all tissues and plays an important role in the
recycling of proline from imidodipeptides (derived from deg-
radation products of collagen) for collagen re-synthesis
(Yaron and Naider 1993) and cell growth (Emmerson and
Phang 1993). The efficiency of recycling of proline was found
to be about 90 % (Jackson et al. 1975). It is evident that an
absence of prolidase severely impedes the recycling of colla-
gen proline. Some clinical symptoms related to collagen def-
icit can be attributed to prolidase deficiency (Freij et al. 1984;
Cabrera et al. 2004; Lupi et al. 2008). On the other hand, an
increased activity of liver prolidase was found during the
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fibrotic process (Myara et al. 1987). There was a posi-
tive correlation between prolidase activity and fibrosis
scores in the lung (Türkbeyler et al. 2012). It suggests
that the enzyme activity (despite the collagen gene ex-
pression) may be a step-limiting factor in regulation of
collagen biosynthesis (Surazynski et al. 2008a). A sig-
nificant increase in serum prolidase activity was ob-
served in patients with hypertension, which was
interpreted as evidence of increased collagen degrada-
tion with a higher collagen turnover rate in hypertension
tissues, contributing to left ventricular hypertrophy
(Demirbag et al. 2007).
Collagen, which accounts for about one third of total body
proteins, is not only essential for the maintenance of connec-
tive tissue architecture. The interaction between cells and ex-
tracellular matrix (ECM) proteins, e.g., collagen, can regulate
cellular gene expression, differentiation, and growth (Bissel
1981; Carey 1991). The interaction is mediated by specific
cell surface receptors of integrin family. The α2β1 integrin is
known as a main collagen receptor. Activation of this receptor
by collagen ligation initiates cascade of signaling pathway
including FAK, Src, Shc, Grb2, Sos, Ras, Raf and MAP ki-
nases, ERK1, and ERK2 (Boudreau and Jones 1999).
Decrease in collagen availability for integrin receptor interac-
tion may therefore potentially alter cellular metabolism.
Prolidase activity is stimulated through a signal mediated by
collagen–β1 integrin receptor interaction (Palka and Phang
1997, 1998). This pathway is known to be involved in phos-
phorylation of several intracellular proteins, including
prolidase (Surazynski et al. 2001).
Another important point of collagen biosynthesis regula-
tion is at the level of insulin-like growth factor-I receptor
(IGF-IR). IGF-I is one of the potent collagen-stimulating fac-
tor in collagen-synthesizing cells (Goldstein et al. 1989).
Stimulated IGF-I receptor induces interaction of several sig-
naling proteins, such as Grb2, Src, and Shc. This interaction
allows activating further cascade of signaling pathway
through Sos, Ras, and Raf proteins and, subsequently, two
MAP kinases—ERK1 and ERK2 (Werner and Le Roith
2000). The end point of this phenomenon is induction of some
transcription factors that regulate cellular metabolism. Some
of these activities are regulated through NF-κB, the known
inhibitor of collagen gene expression (Kouba et al. 1999).
On the other hand, transforming growth factor beta 1
(TGF-β1) may take part in the stimulation of collagen biosyn-
thesis (Surazynski et al. 2010). It was documented in studies
where anti-TGF-β1 antibody or gene silencing by si-TGF-β1
counteracted TGF-β1-dependent increase in collagen type I
production (Jiang et al. 2012).
Considering the above mentioned factors, we studied the
cellular mechanisms for the effect of enalapril-prodrug and
enalaprilat-active form of the drug on collagen biosynthesis
in cultured human dermal fibroblasts.
Materials and methods
Alkaline phosphatase-labeled anti-mouse IgG, anti-rabbit IgG,
and anti-goat IgG antibodies, bacterial collagenase, enalapril
maleate salt and enalaprilat dihydrate (dissolved in DMEM),
Fast BCIP/NBT reagent, L-glycyl-proline, L-proline, monoclo-
nal (rabbit) TGF-β1 antibody, and monoclonal (mouse) anti-
IGF-IR antibodywere provided by SigmaCorp., USA., as were
most other chemicals and buffers used. Dulbecco’s minimal
essential medium (DMEM) and fetal bovine serum (FBS) used
in cell culture were products of Gibco, USA. Glutamine, pen-
icillin, and streptomycin were obtained from Quality
Biologicals Inc., USA. Nitrocellulose membrane (0.2 μm), so-
dium dodecylsulphate (SDS), polyacrylamide, molecular
weight standards, and Coomassie Briliant Blue R-250 were
received from Bio-Rad Laboratories, USA. L-5[3H] proline
(28 Ci/mmol) was purchased from Amersham, UK.
Monoclonal (mouse) anti-β1, polyclonal (rabbit) anti-α2-
integrin and NF-κB p65 antibodies, and polyclonal (goat)
anti-β-actin antibody were the products of Santa Cruz
Biotechnology Inc., USA. Polyclonal anti-human prolidase an-
tibodywas donated byDr. James Phang (NCI-Frederick Cancer
Research and Development Center, Frederick, MD, USA).
Tissue culture
All studies were performed on normal human skin fibroblasts
(CRL-1474), which were purchased from American Type
Culture Collection, Manassas, VA, USA. The cells were main-
tained in DMEM supplemented with 10 % fetal bovine serum
(FBS), 2 mmol/l glutamine, 50 U/ml penicillin, and 50 μg/ml
streptomycin at 37 °C in a 5 % CO2 incubator. Cells were
counted in hemocytometer and cultured at 1 × 105 cells per well
in 2 ml of growth medium in six-well plates (Costar). Cells
reached confluence at day 6, and in most cases, such cells were
used for assays. Cells were used in the 8th to 14th passages.
Determination of prolidase activity
The activity of prolidase was determined according to the
method of Myara et al. (1982). Protein concentration was
measured by the method of Lowry et al. (1951). Enzyme
activity was reported as nanomoles of proline released from
synthetic substrate, during one minute per milligram of super-
natant protein of cell homogenate.
Collagen production
Incorporation of radioactive precursor into proteins was mea-
sured after labeling of confluent cells in growth medium with
enalapril-prodrug and enalaprilat-active form for 24 h with
5[3H] proline (5 μCi/ml, 28 Ci/mM) as described previously
(Oyamada et al. 1990). Incorporation of tracer into collagen
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was determined by digesting proteins with purified
Clostridium histolyticum collagenase, according to the meth-
od of Peterkofsky et al. (1982). Results are shown as com-
bined values for cell plus medium fractions.
SDS-PAGE
Slab SDS-polyacrylamide gel electrophoresis (PAGE) was
used, according to the method of Laemmli (1970), by using
10 % SDS-polyacrylamide gel.
Western immunoblot analysis
After SDS-PAGE, the gels were allowed to equilibrate for
5 min in 25 mmol/l Tris and 0.2 mol/l glycine in 20 % (v/v)
methanol. The protein was transferred to 0.2-μm pore-sized
nitrocellulose at 100 mA for 1 h by using a LKB 2117
Multiphor II electrophoresis unit. The nitrocellulose was in-
cubated with the following: monoclonal anti-β1, polyclonal
anti-α2-integrin, and NF-κB p65 antibodies at concentration
1:1000; polyclonal antibody against β-actin at concentration
1:3000; polyclonal antibody against prolidase at concentration
1:5000; and monoclonal antibodies against IGF-IR and
TGF-β1 at concentration 1:1000 in 5 % dried milk in TBS-
T (20 mmol/l Tris-HCl buffer, pH 7.4, containing 150 mmol/l
NaCl and 0.05 % Tween 20) for 1 h. In order to analyze β1
integrin subunit and IGF-IR second antibody-alkaline phos-
phatase conjugated, anti-mouse IgG (whole molecule) was
added at concentration 1:7500 in TBS-T; in order to analyze
prolidase, α2 integrin subunit, TGF-β1, and NF-κB p65 sec-
ond antibody alkaline phosphatase conjugated, anti-rabbit IgG
(whole molecule) was added at concentration 1:5000; and, in
order to analyze β-actin second antibody-alkaline phospha-
tase conjugated, anti-goat IgG (whole molecule) was added
at concentration 1:5000 in TBS-T and incubated for 30 min
with slow shaking. Then, nitrocellulose was washed with
TBS-T (5 × 5 min) and submitted to Sigma-Fast BCIP/NBT
reagent. The intensity of the bands was quantified by densito-
metric analysis.
Statistics
In all experiments, the mean values for three independent
experiments done in duplicates ± standard deviation (SD)
were calculated. The results were submitted to statistical anal-
ysis using one- way ANOVA followed by Tukey test,
accepting *P<0.05 as significant versus control.
Results
Collagen biosynthesis and prolidase activity were measured in
confluent human dermal fibroblasts, which have been treated
with 0.3 and 0.5 mM enalapril and enalaprilat (dissolved in
DMEM). As can be seen in Fig. 2, 24-h incubation of conflu-
ent fibroblasts in the medium containing 10 % of FBS and
different concentrations of enalapril or enalaprilat contributed
to increase in collagen biosynthesis (Fig. 1a) and prolidase
activity (Fig. 1b) in a dose-dependent manner. At 0.3 and
0.5 mM, enalapril induced increase in collagen biosynthesis
to about 114 and 134 %, respectively. After 24-h incubation,
enalaprilat at 0.3 and 0.5 mM contributed also to increase in
collagen biosynthesis to about 138 and 159 %, respectively
(Fig. 1a).
Prolidase activity was increased to about 126 and 132 % of
control at 0.3 and 0.5 mMof enalapril, respectively. At 0.3 and
0.5 mM, enalaprilat induced prolidase activity to about 128
and 142 % of control, respectively (Fig. 1b).
Increase in prolidase activity due to 24-h treatment of fi-
broblasts with enalapril or enalaprilat was accompanied by
increase in the expression of the enzyme as shown by
Western immunoblot analysis (Fig. 2a).
The data shows that both, enalapril and enalaprilat, induced
increase in collagen biosynthesis in skin fibroblasts and
Fig. 1 Collagen biosynthesis (a) measured as 5[3H] proline
incorporation into proteins susceptible to the action of bacterial
collagenase and prolidase activity (b) in confluent human skin
fibroblasts incubated for 24 h in the medium containing 10 % FBS and
different concentrations of enalapril and enalaprilat. The results present
themean values from six assays ± SD. *P<0.05; **P<0.01; ***P<0.001
compared with the control
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suggests that the increase may result from activation of
prolidase activity and expression.
Collagen biosynthesis and prolidase activity were previ-
ously shown to be regulated due to the signal induced by
activated α2β1 integrin receptor (Palka and Phang 1997;
Ivaska et al. 1999) as well as insulin-like growth factor-I re-
ceptor (IGF-IR) (Goldstein et al. 1989) and transforming
growth factor beta (TGF beta) (McAnulty et al. 1991;
Surazynski et al. 2010). Therefore, the expression of α2β1
integrin receptor (receptor for type I collagen), IGF-IR, and
TGF-β1 were measured by Western immunoblot analysis. As
can be seen in Fig. 2b, c, 24-h treatment of fibroblasts with
0.5 mM enalapril or enalaprilat contributed to a distinct in-
crease in the expression of α2 and β1 integrin subunits, com-
pared to the control cells (Fig. 2b, c, line 1). In addition, as
shown in Fig. 2d, an increase in IGF-I receptor expression was
found in enalapril- and enalaprilat-treated cells, compared to
control cells. Simultaneously, we have found an increase in
the expression of TGF-β1 (Fig. 2e) and NF-κB p65 (Fig. 2f),
the known inhibitor of collagen gene expression (Kouba et al.
1999), compared to control cells (Fig. 2e, f, line 1).
In view of this data, it seems that ability of enalapril and
enalaprilat to induce collagen biosynthesis may involve increase
in prolidase activity and expression, and increase in α2β1
integrin, IGF-I receptor, TGF-β1, and NF-κB p65 expressions.
Discussion
The finding that enalaprilat gives a lower incidence of dermato-
logical manifestations than results from other ACE-I treatment,
captopril (Davies et al. 1984), led us to investigate its role in
collagen biosynthesis in fibroblasts—the main collagen synthe-
sizing cells (Makela et al. 1990). It is well established that
prolidase, providing proline for collagen biosynthesis, is a rate-
limiting factor in regulation of this process (Karna et al. 2000,
2001; Galicka et al. 2001; Surazynski et al. 2008a). Therefore,
the mechanism of prolidase activity regulation is of considerable
interest. In contrast to captopril, enalaprilat had no inhibitory
effect on porcine kidney prolidase (PKP) (King et al. 1989). In
fact, in our previous studies (Karna et al. 2010), we found that
exposure of fibroblasts to captopril contributed to a decrease in
prolidase activity, and expression of α2β1 integrin receptor and
IGF-IR, suggesting underlying mechanism of captopril-
dependent inhibition of collagen biosynthesis. It seems that in
view of dermatological manifestation that accompanies capto-
pril therapy, the above mechanism may be of great importance.
In the present study, we found that enalapril and enalaprilat
contributed to increase in prolidase activity. Their effect on the
activity of other enzymes was also observed (Männistö et al.
2001). The constellation of changes induced by studied ACE
inhibitors found in this study suggests an important role of
prolidase in upregulation of collagen synthesis. It supports our
previous studies on prolidase-dependent regulation of collagen
biosynthesis (Karna et al. 2006). Several other studies suggest
that prolidase-dependent regulation of collagen biosynthesis
may take place at the transcriptional level. The transfection of
colorectal cancer cells with prolidase vector inhibited NF-κB
expression (Surazynski et al. 2008a), well-recognized inhibitor
of expression of α1 and α2 subunits of type I collagen (Kouba
et al. 1999; Rippe et al. 1999; Miltyk et al. 2007). Another
evidence for the role of prolidase in regulation of NF-κB expres-
sion provides experiment showing that inhibition of prolidase
activity by Cbz-Pro contributed to upregulation of NF-κB ex-
pression in fibroblasts (Surazynski et al. 2008a). In contrast, our
data showed that enalapril- and enalaprilat-dependent increase in
collagen biosynthesis is accompanied by an increase in the ex-
pression of NF-κB p65. Although it is accepted that enalapril
inhibits NF-kB-induced inflammatory responses in several ex-
perimental Bin vivo^ models (Kushwaha and Jena 2012), our
data on enalapril effect on NF-kB p65 expression in cultured
Fig. 2 Western blot analysis for prolidase (a),α2 integrin receptor (b),β1
integrin receptor (c), IGF receptor (d), TGF-β1 (e), and NF-κB p65 (f) in
control human skin fibroblasts (lane 1) and cultured in the medium con-
taining 0.5mMof enalapril (lane 2) or 0.5mMof enalaprilat (lane 3). The
mean values of six pooled cell homogenate extracts from six separate
experiments are presented. The intensity of the bands was quantified by
densitometric analysis. Densitometry was done with BioSpectrum Imag-
ing System and presented as an arbitrary units. The same amount of
supernatant protein (20 μg) was run in each lane. The expression of β-
actin served as a control for protein loading (g)
680 Naunyn-Schmiedeberg's Arch Pharmacol (2015) 388:677–683
fibroblasts showed contrary results. It cannot be ruled out that in
the experimental conditions, enalapril upregulates coordinately
expression of both NF-kB and IGF-IR (shown in our studies)
since IGF-IR promoter contains NF-kB binding site (Ma et al.
2006). Such a hypothesis seems to be reasonable since recently
it was found that enalapril and nifedipine differentially regulate
33 genes involved in the pathogenesis of cardiovascular diseases
(Lee et al. 2013).
Enalaprilat as an angiotensin-converting enzyme inhibitor
(ACE-I) has a pseudo-peptide structure with a proline residue
at the position P′2. This proline residue is also present in the
natural substrate of ACE, angiotensin I, and it has been sug-
gested that the preference of proline at position P′2 of the
peptide may reside in its rigid conformation that allows the
carboxy terminus to be placed in a favorable alignment for the
interaction with a positively charged amino acid of the active
site of the enzyme. Important role of proline moiety at the
binding process was proposed (Andújar-Sánchez et al. 2004).
There are some evidence that ACE-Is increase synthesis of
collagen, one of the major constituents of the atherosclerotic
cap (Claridge et al. 2004). Rhaleb et al. (2001) found that
ACE-Is through indirect mechanism may contribute to regu-
lation of collagen synthesis. We used a range of ACE inhibi-
tors at concentrations up to 0.5 mM because of our previous
experience with captopril (Karna et al. 2010). Some studies
Bin vitro^ were performed with higher ACE-I concentration
(10 mmol/l) (Mailloux et al. 2003).
The use of ACE-Is in other animal models of atherosclerosis
has shown an increase in the extracellular matrix proteins
(Rabbani and Topol 1999). These phenomena were explained
by the upregulation of collagen synthesis, and the presence of
increased quantities of collagen in the fibrous cap (Claridge et al.
2004). Moreover, angiotensinogen, angiotensin-converting en-
zyme (ACE), and angiotensin II receptor are expressed in skin
(Steckelings et al. 2004). It is known that ACE inhibitors might
suppress skin disfunction and inflammatory response mediated
through the angiotensin II pathway. Treatment with the ACE
inhibitor, enalapril, counteracted UVB-induced wrinkles and
skin damage (Matsuura-Hachiya et al. 2013).
Some studies have shown diverse effects of different rep-
resentatives of ACE-Is on tissue collagen metabolism.
Perindopril and ramipril prevented overexpression of type
IV collagen mRNA in diabetic vessels (Cooper et al. 1998;
Gilbert et al. 1998), while quinapril had no effect on collagen
type I expression (Hernández-Presa et al. 1998).
Some studies demonstrated that captopril and enalapril im-
proved pulmonary fibrosis in the lung tissue (Ghazi-Khansari
et al. 2007). Early application of enalapril following dermal
injury reduces formation of hypertrophic scars, probably be-
cause of its downregulatory effects on type III collagen pro-
duction (Uzun et al. 2013). The mechanism of this process
may involve TGF-β1 participation (Tang et al. 2009; Jiang
et al. 2012; Uzun et al. 2013).
In fact, our data show that enalapril and enalaprilat both
increase expression of TGF-β1. Moreover, other authors
found that products of catalytic activity of prolidase, Pro and
HyPro, induced increase in the amount of TGF-β1 and recep-
tor expression for TGF-β1 (Surazynski et al. 2010).
Collagen is known as a ligand for α2β1 integrin.
Previously, it has been shown that α2β1 integrin receptor is
involved in signaling, which regulates collagen biosynthesis
(Ivaska et al. 1999) and prolidase activity (Palka and Phang
1994, 1997). Another important point of collagen biosynthesis
regulation is at the level of insulin-like growth factor-I recep-
tor (IGF-IR). IGF-I is one of the most potent collagen-
stimulating factor in collagen-synthesizing cells (Goldstein
et al. 1989). Therefore, we considered α2β1 integrin and
IGF-IR as a potential target in enalapril- and enalaprilat-
induced increase of the above processes.
Our observations suggest that studied drugs increase colla-
gen biosynthesis in fibroblasts primarily through increase of
α2β1 integrin receptor and IGF-I-IR expressions. Presumably,
increase in prolidase activity in fibroblasts due to enalapril and
enalaprilat action is a result of increase of signaling by α2β1
integrin and IGF-IR. Bothβ1 integrin (Palka and Phang 1997)
and IGF-IR (Miltyk et al. 1998) signaling were found to play
important role in prolidase activity regulation.
Although several studies on animal models have shown
that enalapril and enalaprilat treatment reduces fibrosis in
some tissues, it cannot correspond to reduced collagen syn-
thesis. Upregulation of collagen synthesis may reflect intersti-
tial remodeling leading to increase or decrease of tissue colla-
gen content depending on the rate of collagen degradation. It
was supported by some studies showing that ACE inhibitors
increase type III collagen synthesis (Claridge et al. 2004).
Conclusion
The results of present study suggest that in fibroblasts, enala-
pril and enalaprilat may exert its effect on collagen biosynthe-
sis through stimulation of prolidase activity and upregulation
of expressions of prolidase, α2β1 integrin, IGF-IR, TGF-beta
1, and NF-κB p65.
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